Last reviewed · How we verify
Wujia Yizhi granules — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Wujia Yizhi granules (Wujia Yizhi granules) — Sichuan Jishengtang Pharmaceutical Co., Ltd.. Wujia Yizhi granules' mechanism is not well-documented.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Wujia Yizhi granules TARGET | Wujia Yizhi granules | Sichuan Jishengtang Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Wujia Yizhi granules CI watch — RSS
- Wujia Yizhi granules CI watch — Atom
- Wujia Yizhi granules CI watch — JSON
- Wujia Yizhi granules alone — RSS
Cite this brief
Drug Landscape (2026). Wujia Yizhi granules — Competitive Intelligence Brief. https://druglandscape.com/ci/wujia-yizhi-granules. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab